| 产品名称: | KB |
|---|---|
| 商品货号: | TS259023 |
| <strong>Cell line </strong>: | KB |
| DSMZ no. : | TS259023 |
| Species : | confirmed as human with IEF of AST, MDH |
| Cell type : | cervix carcinoma (derivative of HELA) |
| Origin : | originally described as "epidermoid carcinoma established from the mouth of a Caucasian man in 1954"; however, as shown by DSMZ DNA fingerprinting (see below) this cell line must be considered an HELA subclone (human cervix carcinoma, see HELA DSM ACC 57) |
| Reference(s) : | 14499, 14710, 14709 |
| Biosafety level : | 1 |
| Risk assessment : | The cell line is infected with papilloma virus type 18 (HPV-18). The cells contain several copies as proviruses integrated into the eukaryotic genome. The integrated virus genomes are incomplete and exhibit 2-3 kb deletions of the E2-L2 region. An activation and transmission of the HPV-18 during handling of the cell line is improbable. The cell line is categorized biosafety level 1. |
| Permissions and restrictions : | A |
| <strong> </strong>: | DSMZ Scientific Data: |
| Morphology: | adherent cells, epithelial-like, growing as monolayers; image; image; image |
| Medium : | 90% MEM (with Earles salts) + 10% h.i. FBS + MEM non-essential amino acids + 0.075% Na-bicarbonate |
| Subculture : | split confluent culture 1:3 to 1:5 every 3-6 days using trypsin/EDTA; seed out at ca. 1-2 x 106 cells/80 cm2 |
| Incubation : | at 37 °C with 5% CO2 |
| Doubling time : | ca. 30 hours |
| Harvest : | about 5-10 x 106 cells/80 cm2 flask |
| Storage : | frozen with 70% medium, 20% FBS, 10% DMSO |
| Mycoplasma : | negative in DAPI, microbiological culture, RNA hybridization, PCR assays |
| Immunology : | To inquire about expression of EpCAM and intermediate filaments, contact hilmar.quentmeier@dsmz.de. |
| Fingerprint : | same DNA as HELA using multiplex PCR of minisatellite markers |
| Cytogenetics : | human hypertriploid karyotype with 8% polyploidy - 76(73-78)<3n> |
| Viruses : | ELISA: reverse transcriptase negative; PCR: EBV -, HBV -, HCV -, HIV-1 -, HIV-2 -, HPV +, HTLV-I/II -, MLV -, SMRV - |
| 产品名称: | KB |
|---|---|
| 商品货号: | TS259023 |
| <strong>Cell line </strong>: | KB |
| DSMZ no. : | TS259023 |
| Species : | confirmed as human with IEF of AST, MDH |
| Cell type : | cervix carcinoma (derivative of HELA) |
| Origin : | originally described as "epidermoid carcinoma established from the mouth of a Caucasian man in 1954"; however, as shown by DSMZ DNA fingerprinting (see below) this cell line must be considered an HELA subclone (human cervix carcinoma, see HELA DSM ACC 57) |
| Reference(s) : | 14499, 14710, 14709 |
| Biosafety level : | 1 |
| Risk assessment : | The cell line is infected with papilloma virus type 18 (HPV-18). The cells contain several copies as proviruses integrated into the eukaryotic genome. The integrated virus genomes are incomplete and exhibit 2-3 kb deletions of the E2-L2 region. An activation and transmission of the HPV-18 during handling of the cell line is improbable. The cell line is categorized biosafety level 1. |
| Permissions and restrictions : | A |
| <strong> </strong>: | DSMZ Scientific Data: |
| Morphology: | adherent cells, epithelial-like, growing as monolayers; image; image; image |
| Medium : | 90% MEM (with Earles salts) + 10% h.i. FBS + MEM non-essential amino acids + 0.075% Na-bicarbonate |
| Subculture : | split confluent culture 1:3 to 1:5 every 3-6 days using trypsin/EDTA; seed out at ca. 1-2 x 106 cells/80 cm2 |
| Incubation : | at 37 °C with 5% CO2 |
| Doubling time : | ca. 30 hours |
| Harvest : | about 5-10 x 106 cells/80 cm2 flask |
| Storage : | frozen with 70% medium, 20% FBS, 10% DMSO |
| Mycoplasma : | negative in DAPI, microbiological culture, RNA hybridization, PCR assays |
| Immunology : | To inquire about expression of EpCAM and intermediate filaments, contact hilmar.quentmeier@dsmz.de. |
| Fingerprint : | same DNA as HELA using multiplex PCR of minisatellite markers |
| Cytogenetics : | human hypertriploid karyotype with 8% polyploidy - 76(73-78)<3n> |
| Viruses : | ELISA: reverse transcriptase negative; PCR: EBV -, HBV -, HCV -, HIV-1 -, HIV-2 -, HPV +, HTLV-I/II -, MLV -, SMRV - |